The Secukinumab Biosimilar Anti-IL17A Antibody is a cutting-edge research tool designed for studying the interleukin-17A (IL-17A) pathway in immune responses. This biosimilar antibody, similar in structure and function to secukinumab, specifically targets IL-17A, a key cytokine involved in inflammation and autoimmune diseases.With high specificity and reactivity to IL-17A, this antibody is ideal for applications such as ELISA, Western blot, and immunohistochemistry, enabling researchers to detect and analyze IL-17A expression in various samples.
By blocking the activity of IL-17A, this antibody can provide valuable insights into the role of IL-17A in immune-mediated diseases and potential therapeutic interventions.The Secukinumab Biosimilar Anti-IL17A Antibody is a powerful tool for researchers in immunology, rheumatology, and related fields, offering a deeper understanding of the IL-17A pathway and its impact on inflammatory and autoimmune conditions. Its use may lead to the development of novel treatment strategies targeting IL-17A for improved management of these diseases.
Product Name:
Secukinumab (Anti-IL17A) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0119
Target:
IL17A
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
AIN457
Description:
Anti-IL17A(secukinumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
